Close Menu

Politics influenced FDA's approval of a device that assists in knee-replacement surgeries, reports the New York Times. Scientific reviewers at FDA concluded that the Menafelx device, made by ReGen Biologic, was unsafe and often failed. Managers overruled that decision after pressure from New Jersey (where the device is manufactured) politicians, Senators Robert Menendez and Frank Lautenberg and Representatives Frank Pallone Jr. and Steven Rothman, all Democrats, the Times says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.